↓ Skip to main content

Cochrane Database of Systematic Reviews

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease

Overview of attention for article published in this source, September 2013
Altmetric Badge

Mentioned by

news
1 news outlet
blogs
1 blog
policy
2 policy sources
twitter
23 X users
facebook
2 Facebook pages
wikipedia
8 Wikipedia pages

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
64 Mendeley
citeulike
1 CiteULike
Title
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
Published by
John Wiley & Sons, Ltd, September 2013
DOI 10.1002/14651858.cd009552.pub2
Pubmed ID
Authors

Cheyne, Leanne, Irvin-Sellers, Melanie J, White, John

Abstract

Tiotropium and ipratropium bromide are both recognised treatments in the management of people with stable chronic obstructive pulmonary disease (COPD). There are new studies which have compared tiotropium with ipratropium bromide, making an update necessary.

X Demographics

X Demographics

The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sweden 1 2%
Unknown 63 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 28%
Student > Bachelor 7 11%
Other 6 9%
Researcher 6 9%
Student > Ph. D. Student 6 9%
Other 13 20%
Unknown 8 13%
Readers by discipline Count As %
Medicine and Dentistry 31 48%
Nursing and Health Professions 9 14%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Social Sciences 3 5%
Chemistry 2 3%
Other 4 6%
Unknown 8 13%